CRB1-associated retinal dystrophies in a Belgian cohort: genetic characteristics and long-term clinical follow-up
- PMID: 33579689
- DOI: 10.1136/bjophthalmol-2020-316781
CRB1-associated retinal dystrophies in a Belgian cohort: genetic characteristics and long-term clinical follow-up
Abstract
Aim: To investigate the natural history in a Belgian cohort of CRB1-associated retinal dystrophies.
Methods: An in-depth retrospective study focusing on visual function and retinal structure.
Results: Forty patients from 35 families were included (ages: 2.5-80.1 years). In patients with a follow-up of >1 year (63%), the mean follow-up time was 12.0 years (range: 2.3-29.2 years). Based on the patient history, symptoms and/or electroretinography, 22 patients (55%) were diagnosed with retinitis pigmentosa (RP), 15 (38%) with Leber congenital amaurosis (LCA) and 3 (8%) with macular dystrophy (MD), the latter being associated with the p.(Ile167_Gly169del) mutation (in compound heterozygosity). MD later developed into a rod-cone dystrophy in one patient. Blindness at initial presentation was seen in the first decade of life in LCA, and in the fifth decade of life in RP. Eventually, 28 patients (70%) reached visual acuity-based blindness (<0.05). Visual field-based blindness (<10°) was documented in 17/25 patients (68%). Five patients (13%) developed Coats-like exudative vasculopathy. Intermediate/posterior uveitis was found in three patients (8%). Cystoid maculopathy was common in RP (9/21; 43%) and MD (3/3; 100%). Macular involvement, varying from retinal pigment epithelium alterations to complete outer retinal atrophy, was observed in all patients.
Conclusion: Bi-allelic CRB1 mutations result in a range of progressive retinal disorders, most of which are generalised, with characteristically early macular involvement. Visual function and retinal structure analysis indicates a window for potential intervention with gene therapy before the fourth decade of life in RP and the first decade in LCA.
Keywords: dystrophy; genetics; retina.
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
CRB1-Associated Retinal Dystrophies: Genetics, Clinical Characteristics, and Natural History.Am J Ophthalmol. 2023 Feb;246:107-121. doi: 10.1016/j.ajo.2022.09.002. Epub 2022 Sep 12. Am J Ophthalmol. 2023. PMID: 36099972 Free PMC article.
-
Genotypic and Phenotypic Characteristics of CRB1-Associated Retinal Dystrophies: A Long-Term Follow-up Study.Ophthalmology. 2017 Jun;124(6):884-895. doi: 10.1016/j.ophtha.2017.01.047. Epub 2017 Mar 21. Ophthalmology. 2017. PMID: 28341475
-
CRB1 maculopathy presenting as fenestrated sheen macular dystrophy with 15-year follow-up.Doc Ophthalmol. 2021 Jun;142(3):381-388. doi: 10.1007/s10633-020-09810-y. Epub 2021 Jan 2. Doc Ophthalmol. 2021. PMID: 33387055
-
CRB1 mutations in inherited retinal dystrophies.Hum Mutat. 2012 Feb;33(2):306-15. doi: 10.1002/humu.21653. Epub 2011 Dec 27. Hum Mutat. 2012. PMID: 22065545 Free PMC article. Review.
-
[Genotype-Phenotype Correlations in Patients with CRB1 Mutations].Klin Monbl Augenheilkd. 2017 Mar;234(3):289-302. doi: 10.1055/s-0043-103961. Epub 2017 Mar 29. Klin Monbl Augenheilkd. 2017. PMID: 28355663 Review. German.
Cited by
-
Identification of Arhgef12 and Prkci as genetic modifiers of retinal dysplasia in the Crb1rd8 mouse model.PLoS Genet. 2022 Jun 8;18(6):e1009798. doi: 10.1371/journal.pgen.1009798. eCollection 2022 Jun. PLoS Genet. 2022. PMID: 35675330 Free PMC article.
-
CRB1-Associated Retinal Dystrophies: Genetics, Clinical Characteristics, and Natural History.Am J Ophthalmol. 2023 Feb;246:107-121. doi: 10.1016/j.ajo.2022.09.002. Epub 2022 Sep 12. Am J Ophthalmol. 2023. PMID: 36099972 Free PMC article.
-
Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.Int J Mol Sci. 2023 Apr 19;24(8):7481. doi: 10.3390/ijms24087481. Int J Mol Sci. 2023. PMID: 37108642 Free PMC article. Review.
-
CRB1-associated retinal dystrophy presenting as self-resolving opsoclonus and posterior uveitis.Am J Ophthalmol Case Rep. 2022 Feb 20;26:101444. doi: 10.1016/j.ajoc.2022.101444. eCollection 2022 Jun. Am J Ophthalmol Case Rep. 2022. PMID: 35243176 Free PMC article.
-
Assessment of CRB1-Associated Retinopathies Using the S-MAIA Fast Protocol and Spectral-Domain Optical Coherence Tomography.Biomedicines. 2025 Feb 21;13(3):555. doi: 10.3390/biomedicines13030555. Biomedicines. 2025. PMID: 40149532 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials